"Subsidizing Wegovy and Mounjaro with Taxpayer Money?"... The Region Pushing for South Korea's First 'Obesity Medication Support Ordinance'

Hee Chan Kim Reporter

jujui@hanmail.net | 2026-11-18 08:50:49



The Jeonnam-Gwangju Integrated Metropolitan Council is pushing to become the first local government in South Korea to subsidize the purchase costs of non-reimbursed obesity treatments, such as Wegovy and Mounjaro, using local government funds. While the initiative aims to assist untreated obesity patients, controversies regarding its appropriateness are anticipated due to an estimated cost of up to 283.8 billion won over five years and the absence of specific eligibility criteria.

According to the Jeonnam-Gwangju Integrated Metropolitan Council on the 17th, a group of 27 council members, including People Power Party proportional representative Lee O-sook, recently proposed the "Jeonnam-Gwangju Integrated Metropolitan City Ordinance on Supporting the Purchase Costs of Obesity Treatment Medications."

The proposed ordinance stipulates that individuals who have resided in the integrated city for at least one year, have been diagnosed with obesity, and have been prescribed non-reimbursed treatments may receive full or partial subsidies for their medication costs. Basic livelihood security recipients, the near-poor class, and young adults could be designated as primary support targets.

Representative Lee’s office explained that while local governments across the country currently have ordinances for obesity prevention and management, this is the first time a legislative bill has been proposed to directly subsidize the purchase of non-reimbursed obesity medications using local tax revenues.

Concerns Over Eligibility and Financial Burden

Although the ordinance is intended to proactively identify and support patients with severe obesity, the current draft lacks concrete criteria to screen beneficiaries, such as the degree of obesity or the presence of complications. It also remains unclear how support for severe obesity treatments will be distinguished from subsidies for general weight management medications.

Financial burdens are another major concern. According to the cost estimation attached to the ordinance, between 56.76 billion and 283.8 billion won in pure city funds would be required over the five-year period from 2027 to 2031 (annual costs ranging from 11.35 billion to 56.76 billion won). This calculation was derived by estimating about 19,700 individuals with a Body Mass Index (BMI) of 30 or higher out of 262,664 low-income residents, and assuming that 10% to 50% of them would receive one year of medication support.

However, critics point out that a BMI of 30 or higher includes not only extreme obesity but also stage 2 obesity, and that the cost estimate fails to encompass general residents who could potentially qualify under the ordinance, limiting its usefulness in assessing the true scope of the project. Experts note that if supporting severe patients is the primary objective, the government should have first established clear criteria for disease severity, medical necessity, income levels, individual subsidy amounts, and duration before calculating the budget.

Future Hurdles: Equity and Central Government Consultations

Additional challenges include whether it is appropriate to use local finances to support expensive obesity treatments that are not covered by the national health insurance system, and how to secure fairness compared to patients suffering from other diseases. Even if the ordinance is enacted, implementing the program will require formal consultation procedures to establish new social security systems with the Ministry of Health and Welfare.

Representative Lee O-sook explained, "Originally, the support proposal was structured mainly around low-income families, but we reflected the opinions of co-sponsoring council members to expand the target groups. The cost estimate is a rough figure assuming a broad scope of support, and the actual number of beneficiaries and available budget scale will be adjusted through consultations with the central government following the enactment of the ordinance."

[ⓒ Global Economic Times. 무단전재-재배포 금지]

WEEKLY HOT